SELLAS Life Sciences (SLS) Equity Ratio (2010 - 2026)
SELLAS Life Sciences (SLS) reported Equity Ratio of 0.94 for Q1 2026, up 18.47% year-over-year from 0.79 in Q1 2025, and up 4.0% on a QoQ basis from 0.9 in Q4 2025.
SELLAS Life Sciences (SLS) has 17 years of Equity Ratio data on file, last reported at 0.94 in Q1 2026.
- Quarterly Equity Ratio rose 18.47% year-over-year to 0.94 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.94 (up 18.47% YoY) and the FY2025 annual result came in at 0.9, up 85.72% from the prior year.
- Equity Ratio advanced to 0.94 in Q1 2026 per SLS's latest filing, from 0.9 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.94 in Q1 2026 and bottomed at 1.28 in Q4 2023.
- The 5-year median for Equity Ratio is 0.48 (2022), against an average of 0.38.
- The widest annual swing landed in 2023, when Equity Ratio sank 653.7%; it then surged 320.11% in 2025.
- Tracing SLS's Equity Ratio over 5 years: stood at 0.23 in 2022, then slumped by 653.7% to 1.28 in 2023, then surged by 137.98% to 0.49 in 2024, then soared by 85.72% to 0.9 in 2025, then grew by 4.0% to 0.94 in 2026.
- Per Business Quant, the three latest SLS Equity Ratio figures stand at 0.94 (Q1 2026), 0.9 (Q4 2025), and 0.89 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.21 |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | 0.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.94 |
| Dec 31, 2025 | 0.90 |
| Sep 30, 2025 | 0.89 |
| Jun 30, 2025 | 0.81 |
| Mar 31, 2025 | 0.79 |
| Dec 31, 2024 | 0.49 |
| Sep 30, 2024 | 0.60 |
| Jun 30, 2024 | 0.19 |
| Mar 31, 2024 | 0.40 |
| Dec 31, 2023 | -1.28 |
| Sep 30, 2023 | -0.47 |
| Jun 30, 2023 | 0.26 |
| Mar 31, 2023 | 0.45 |
| Dec 31, 2022 | 0.23 |
| Sep 30, 2022 | 0.48 |
| Jun 30, 2022 | 0.59 |
| Mar 31, 2022 | 0.19 |
| Dec 31, 2021 | 0.77 |
| Sep 30, 2021 | 0.70 |
| Jun 30, 2021 | 0.77 |
| Mar 31, 2021 | 0.71 |
| Dec 31, 2020 | 0.61 |
| Sep 30, 2020 | 0.43 |
| Jun 30, 2020 | 0.26 |
| Mar 31, 2020 | 0.47 |
| Dec 31, 2019 | 0.37 |
| Sep 30, 2019 | 0.50 |
| Jun 30, 2019 | 0.57 |
| Mar 31, 2019 | 0.20 |
| Dec 31, 2018 | 0.31 |
| Sep 30, 2018 | 0.48 |
| Jun 30, 2018 | -0.08 |
| Mar 31, 2018 | -0.04 |
| Dec 31, 2017 | 0.06 |
| Sep 30, 2017 | 0.30 |
| Jun 30, 2017 | 0.32 |
| Mar 31, 2017 | 0.39 |
| Dec 31, 2016 | -0.78 |
| Sep 30, 2016 | 0.33 |
| Jun 30, 2016 | 0.28 |
| Mar 31, 2016 | 0.19 |
| Dec 31, 2015 | -0.15 |
| Sep 30, 2015 | 0.39 |
| Jun 30, 2015 | 0.48 |
| Mar 31, 2015 | 0.54 |
| Dec 31, 2014 | 0.46 |
| Sep 30, 2014 | 0.39 |
| Jun 30, 2014 | 0.35 |
| Mar 31, 2014 | 0.50 |
| Dec 31, 2013 | 0.07 |
| Sep 30, 2013 | 0.38 |
| Jun 30, 2013 | 0.25 |
| Mar 31, 2013 | 0.38 |
| Dec 31, 2012 | 0.50 |
| Sep 30, 2012 | 0.40 |
| Mar 31, 2012 | -0.37 |
| Dec 31, 2011 | 0.33 |
| Sep 30, 2011 | 0.16 |
| Jun 30, 2011 | 0.22 |
| Dec 31, 2010 | -7.46 |